Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03414034
Title PCM-075 in Combination With Abiraterone and Prednisone in Adult Patients With Metastatic Castration-Resistant Prostate Cancer
Recruitment Recruiting
Gender male
Phase Phase II
Variant Requirements No
Sponsors Trovagene, Inc.
Indications

prostate adenocarcinoma

Therapies

Abiraterone + Onvansertib + Prednisone

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.